• Protocols

• GOG3133

  OPEN TO ACCRUAL

  A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Platinum-Resistant (Part A) and Plat
  
  

• UW24116

  OPEN TO ACCRUAL

  Ph2 trial of Mirvetuximab Soravtansine & Olaparib in Ovarian Peritoneal & Fallopian Tube Cancer